Table 1. Characteristics of eyes with or without VHDs at 1.
Eyes | ||||
without VHD | With VHD(%)* | |||
Factor | (n = 32) | (n = 40) | P value | |
Age, years | 67.2±10.74 | 69.6±9.16 | 0.314 | |
Sex, n | ||||
male | 14 | 18 (56.3%) | 0.916 | |
female | 18 | 22 (55.0%) | ||
History of diabetes, n | ||||
no | 27 | 34 (55.7%) | 0.999† | |
yes | 5 | 6 (54.5%) | ||
Laterality, n | ||||
OD | 13 | 23 (63.9%) | 0.155 | |
OS | 19 | 17 (47.2%) | ||
Preoperative BCVA, logMAR | 0.33±0.273 | 0.30±0.258 | 0.565 | |
Snellen equivalent | 20/43 | 20/40 | ||
Biometric values | ||||
Mean keratometric value, D | 42.6±1.21 | 43.0±1.60 | 0.278 | |
Anterior chamber depth, mm | 2.71±0.439 | 2.59±0.340 | 0.172 | |
Anterior chamber angle, degrees | 34.2±5.92 | 31.8±6.44 | 0.121 | |
Axial length, mm | 24.2±1.14 | 23.6±1.04 | 0.039 | |
Preoperative CRT, µm | 243±21.6 | 242±22.3 | 0.727 | |
Postoperative 1-month BCVA, logMAR | 0.11±0.137 | 0.10±0.175 | 0.766 | |
Snellen equivalent | 20/26 | 20/25 | ||
Postoperative 1-month CRT, µm | 254±24.9 | 259±33.0 | 0.476 |
VHD = vitreous hyper-reflective dot; BCVA = best-corrected visual acuity; logMAR = the logarithm of the minimum angle of resolution; D = diopters; CRT = central subfield retinal thickness.
Results are expressed a mean ± standard deviation.
*Incidence of VHDs in total cases of stated condition.
P values were calculated with the chi-square analysis or Fisher exact test† for categorical variables and t-test for continuous variables.